Health care stocks were rising premarket Monday, with The Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) 0.3% higher.
RadNet (RDNT) stock was up more than 7% after the company posted higher Q2 adjusted earnings and service revenue.
Legend Biotech (LEGN) shares were more than 2% higher after the company reported that it swung to Q2 adjusted earnings as revenue increased during the period.
Novartis (NVS) shares were up more than 1% after the company said two phase III trials assessing ianalumab in adults with active Sjogren's disease met the primary endpoint of showing "statistically significant" improvements in disease activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.